Clinical Trial Update: Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) [Phase 4]

View source ↗

Summary

Phase 4 COLM-Study evaluating the combination of olmesartan with a calcium channel blocker or a low-dose diuretic in high-risk elderly hypertensive patients; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Hypertension

Drugs mentioned

• Olmesartan (olmesartan)

Snippet

Sponsor: COLM Study Research Organization | Conditions: Hypertension, Cardiovascular Disease | Phase 4 | Status: COMPLETED